baber/WOPTO huggingface dataset:
Patent NZ-510362-A (NZ)
Title: Bubble column with one or more perforated trays having a cross-sectional area for each perforation of 0.003 to 3 millimeters squared
Inventor: EICKHOFF HUBERTUS
IPC: B01J19/24
Filed: 1999-09-09
Abstract: A bubble column can be operated using countercurrent flow including perforated trays. The space-time yield of gas-liquid reactions can be considerably increased if the perforated trays have a substantially uniform distribution of holes, if the cross-sectional area of the individual holes is 0.003 to 3 mm2, particularly 0.01 to 0.5 mm2, and if the open area of the trays is 3 to 20%, particularly 3 to 10%, and if the bubble column comprises passages for liquid between adjacent liquid zones. The bubble column can be used for carrying out gas-liquid reactions, such as oxidation reactions with air, with the gas and liquid preferably being passed in countercurrent flow through the column. Cocurrent flow may also be used
Patent NZ-513114-A (NZ)
Title: Use of cyclohexane or pyran anticonvulsant derivatives for treating bulimia nervosa
Inventor: HOOPES SCOTT P
IPC: A61K31/35
Filed: 2000-01-31
Abstract: A compound of formula (I) is used in the manufacture of a medicament to treat bulimia nervosa. In formula (I): X is CH2 or oxygen; R2 to R5 are independently H or alkyl or when X is CH2 R4 and R5 together with the carbons to which they are attached may form a benzene ring or when X is oxygen R2 and R3 and/or R4 and R5 together may form a methylenedioxy group -O- C(R6)(R7)-O- and R6 and R7 are independently H or alkyl or together with the carbons to which they are attached may form a cycloptentyl or cyclohexyl ring.
Patent NZ-514060-A (NZ)
Title: Mixture of popcorn kernels and pellets
Inventor: KERSHMAN ALVIN
IPC: A23L1/18
Filed: 2000-02-07
Abstract: A combination popcorn snack comprising popcorn and starch based pellets is produced by providing a charge of unpopped popcorn kernels and pre-gelatinized starch-based pellets in a weight ratio between 3:1 to 1.25:1 and subjecting the combined charges to microwave energy, whereby the pellets puff and the popcorn pops. The pellets have a moisture content between about 7-14% by weight. An oil slurry may further be added at a ratio of less than about 1:2 oil slurry to popcorn and pellet charge. The popcorn and pellet charge can placed in a container prior to subjection to microwave energy whereby the container may bag or a tub and can include a microwave interactive susceptor. An aqueous coating can be further applied to the pellets on the pellets whereby the coating can comprise a flavour and/or starch. The pellets can puff less than 60 seconds before the popcorn pops.
Patent NZ-515158-A (NZ)
Title: Process for the purification of sterols from hydrocarbon extracts using evaporative fractionation
Inventor: HAMUNEN ANTTI
IPC: C07C401/00
Filed: 2000-04-24
Abstract: A method for separating sterols from neutral substances comprising the sterols, the method comprising: (a) providing a hydrocarbon fraction containing in the neutral substances; (b) optionally washing the hydrocarbon fraction with water; (c) optionally separating the neutral substances from the hydrocarbon; (d) evaporation fractionating the neutral substances from step (c), to obtain a sterol-rich fraction; (e) dissolving the sterol-rich fraction in a solvent and crystallizing the sterols from the solvent; and (f) separating the obtained sterol crystals from the solvent.
Patent NZ-515499-A (NZ)
Title: Advertising or sign reply system using short message service mobile services
Inventor: SMITH BRYAN LESLIE
IPC: H04M11/06
Filed: 2001-11-15
Abstract: An information system comprises: a display identifying a code to be supplied to a text massaging system, the code reacting to a particular product or service; a message originator capable of supplying a text message containing the code to an SMS messaging system; a messaging server capable of receiving an SMS text message from a message system and of discriminating within the received text message the code indicating a specific product or service, of forwarding this code to a data server, of receiving data relating to the specific product or service from the data server and returning this data to the text message originator and a data server capable receiving from a message server the code, translating this as a request for information on a specific product or service and extracting and returning to the message server data relating to that product or service.
Patent NZ-515892-A (NZ)
Title: A fabric loading leader to pull fabric onto a paper machine
Inventor: KORNETT GLENN
IPC: D21F7/00
Filed: 2000-06-16
Abstract: A leader used to pull a seamable papermaker's fabric onto a paper machine comprising at least one section of material comprising yarns which are so oriented so as to distribute the load evenly across and down the fabric.
Patent NZ-517124-A (NZ)
Title: Enhanced method of killing weeds with glyphosate herbicide
Inventor: BECHER DAVID Z
IPC: A01N25/30
Filed: 2000-09-05
Abstract: A  method  of  enhancing  herbicidal  activity  of   a glyphosate  herbicide  comprises adding  to  the  glyphosate herbicide  a  mixture  of a first surfactant  and  a  second surfactant  at  a weight ration of a total surfactant  to  a glyphosate acid equivalent of about 1:30 to about 1:2.   The first  surfactant has a structure comprising a  cationic  or protonatable amino group and a C8-24 hydrocarbyl group.  The second  surfactant  has  the  formula  R-CO-NR'-(CR'2)n-COOM wherein  R  is C7-23 hydrocarbyl group, n is 1 to  4,  m  is hydrogen or a cationic counterion, and the R' groups are  H, C1-4  alkyl or a group -(CH2)m-COOM where m is 1 to 4 and  M is  as defined above, with the proviso that no more than one R' group is the group -(CH2)m-COOM. The first surfactant and the  second  surfactant are in the weight ratio of  1:10  to about 10:1. Also  described  is  a herbicidal composition  comprising  a glyphosate  herbicide  and the first surfactant  and  second surfactant as defined above.
Patent NZ-518095-A (NZ)
Title: Redox reversible HCV proteins with native-like conformation
Inventor: BOSMAN ALFONS
IPC: A61P/
Filed: 2000-10-25
Abstract: The  disclosure  relates  to  HCV  proteins  in  which cysteine   residues   are   reversibly   protected    during purification.   Eventually,  this   purification   procedure results  in  HCV  proteins with biological  activity  and  a native-like    protein    conformation,    which     present corresponding  epitopes. Disclosed also are  drug  screening methods  using  these  HCV  proteins,  and  diagnostic   and therapeutic applications, such as vaccines and drugs.
Patent NZ-518320-A (NZ)
Title: Immuno-interactive fragments of the alphaC subunit of inhibin
Inventor: MILNE-ROBERTSON DAVID MARK
IPC: G01N33/74
Filed: 2000-10-18
Abstract: An isolated antigen-binding molecule binds specifically to an immuno-interactive sequence of the alphaC portion of an inhibin alpha-subunit, or to a variant having at least 75% sequence identity with the immuno-interactive sequence or to a derivative of the immuno-interactive sequence or of the variant wherein the antigen-binding molecule is other than a polyclonal antibody. The immuno-interactive sequence is sequence selected from SEQ ID NOs: 18-20, 55-60 and 68- 73. An isolated polypeptide for inducing an anti-inhibin alpha C subunit immune response comprises a least 6 contiguous residues of an immuno-interactive sequence selected from SEQ ID NOs: 3, 6, 18-20, 35-40, 55-60 and 68- 73. Also described are a method of producing the antigen binding molecule, a method for detecting a mammalian inhibin in a sample and a method for diagnosing a condition associated with aberrant concentration of a mammalian inhibin. The use of the polypeptide or antigen-binding molecule in the manufacture of a medicament for eliciting an immune response in a mammal or treating or preventing a condition associated with an aberrant concentration of inhibin, kits and pharmaceutical composition are described.
Patent NZ-521388-A (NZ)
Title: Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
Inventor: BROWN WILLIAM
IPC: A61P25/02
Filed: 2001-03-30
Abstract: Compounds of formula (I), where R1 is selected from any one of pyridinyl, thienyl, furanyl, imidazolyl, and triazolyl; where each R1 heteroaromatic ring may optionally and independently be further substituted by 1, 2 or 3 substituents selected from straight and branched C1-C6 alkyl, NO2, CF3, C1-C6 alkoxy, chloro, fluoro, bromo, and iodo, wherein the substitutions on the heteroaromatic ring may take place in any position on the ring systems, as well as separate enantiomers of the compounds and salts and pharmaceutical compositions comprising these compounds and their use in therapy, in particular in the management of pain are disclosed.
Patent NZ-527130-A (NZ)
Title: Thermoplastic reinforced hose construction
Inventor: POWELL STEVEN M
IPC: F16L11/08
Filed: 2002-01-08
Abstract: A flexible hose adapted construction for conveying fluids under pressure. The construction includes a core tube having a circumferential inner core tube surface and an opposing circumferential outer core tube surface. A first reinforcement layer surrounds the outer core tube surface, and is formed of one or more filaments of a first fibre. A second fibre reinforcement layer surrounds the first reinforcement layer, and is formed of one or more filaments of a second fibre. The first and second reinforcement layers are bonded together by means of a bonding agent such as an adhesive, resin, plasticizer, tackifier, or solvent, the application of which is controlled to wet only a portion of the filaments of the reinforcement layers. Also claimed is a hose constructed according to the above.
Patent NZ-529105-A (NZ)
Title: An isolated nucleic acid or nucleic acid fragment encoding an abscisic acid-inducible and stress responsive (ASR) polypeptide for a ryegrass (lolium) species
Inventor: SPANGENBERG GERMAN
IPC: C07K14/415
Filed: 2002-05-07
Abstract: An isolated nucleic acid or nucleic acid fragment encoding an abscisic acid-inducible and stress responsive (ASR) polypeptide from a ryegrass (Lolium) species. Also disclosed is a method of modifying a plant response to an environmental stimulus by introducing into the plant an effective amount of nucleic acid. Also disclosed is the use of a nucleic acid as a molecular genetic marker.
Patent NZ-530567-A (NZ)
Title: Stable ready-to-use dosage forms containing coloring matter and active chlorine, and methods of making and using same as disinfectants
Inventor: FREEDMAN SHIMON
IPC: A61L2/16
Filed: 2002-07-16
Abstract: Disclosed is a method of producing a disinfectant or sterilizing liquid, cream, ointment, paste, or gel by dissolving in a solvent a stable ready-to-use dosage form containing coloring matter and an organic chloroxidizer acting as a chlorine donor releasing active chlorine; wherein: the coloring matter is in its maximal level of oxidation; the chloroxidizer with coloring matter has a pH of 4 - 8 and is present in a sufficient quantity to disinfect or sterilize the surface, vessel, or tissue as required while the colored appearance of the liquid, cream, ointment, paste, or gel is stably maintained over a period of time which exceeds the period of time that the disinfectant would be normally used for that purpose.
Patent NZ-530878-A (NZ)
Title: A system and method of fund-raising
Inventor: COSTELLO NEIL EDWARD
IPC: G06Q30/00
Filed: 2002-07-29
Abstract: This system for raising funds includes a web server hosting a community based Internet portal of subscribing providers of goods and/or services with the portal contactable through a user system by subscribers and purchasers. The web server processor interfaces with a web browser adapted to browse information and data on the portal, a database and means for data entry retrieval and processing on the database, computerized fund accounting means adapted to account for on-line and off-line transactions between subscribers, between purchasers, and between subscribers and purchasers. In operation, goods and/or services are provided by subscribers to purchasers under a loyalty arrangement or scheme and wherein provider and purchaser data can be entered, retrieved and processed on the database by the data entry, retrieval and processing means, and on-line and off-line sales transactions under the loyalty arrangement can be accounted for by the accounting means and wherein loyalty benefits and provider subscription fees or a part thereof can be processed, accounted for and allocated for distribution to the benefit of the members of the community.
Patent NZ-532198-A (NZ)
Title: Polymeric micelle composition of an amphiphilic block copolymer and a polylactic acid derivative
Inventor: SEO MIN-HYO
IPC: C08L101/16
Filed: 2002-10-17
Abstract: Polymeric compositions capable of forming stable micelles in an aqueous solution are disclosed, which comprise an amphiphilic block copolymer of a hydrophilic block and a hydrophobic block, and a polylactic acid derivative wherein one end of the polylactic acid is covalently bound to at least one carboxyl group. The carboxyl group of the polylactic acid derivative may be fixed with a di- or tri-valent metal ion, obtained by adding the di- or tri-valent metal ion to the polymeric composition. The polymeric compositions may be applied as a drug delivery system in various forms since poorly water soluble drugs can be entrapped inside the micelles.
Patent NZ-533147-A (NZ)
Title: Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
Inventor: MEGURO MASAKI
IPC: C07D241/20
Filed: 2002-11-25
Abstract: Preventives or remedies for Alzheimer's disease or amyloid protein fibrosis inhibitors are disclosed, which contain, as the active ingredient, at least one nitrogen-containing heteroaryl compound having the general formula (I) or pharmacologically acceptable salts thereof, wherein R1 and R2 represent each H or alkyl; Z1 and Z2 represent each H, alkyl, alkoxy, haloalkyl or halogeno; Z3 represents alkoxy, SH, alkylthio, NH2, mono- or dialkylamino, OH or halogeno; Z4 and Z5 represent each H or halogeno; and A represents 4,6-pyrimidine-1,3-diyl, 1,3,5-triazine-2,6-diyl, etc.
Patent NZ-533387-A (NZ)
Title: Friction fit paint cup connection
Inventor: GOSIS ANATOLY
IPC: B05B12/00
Filed: 2004-06-08
Abstract: A cover-connector for covering and connecting a fluid supply container to a conduit is provided, wherein one of the container and the conduit has a male frustoconical connecting surface and the other one of the container and the conduit has a threaded connecting surface. The cover-connector comprises a conduit side with a conduit connecting region, a container side with a container connecting region, and a passageway between the connecting regions, wherein one of the connecting regions has a female frustoconical surface having an acute frustoconical angle complementary to the male frustoconical connecting surface for frictional connection therebetween, and wherein the other one of the connecting regions has a threaded portion complementary to the threaded connecting surface for threaded connecting therebetween.
Patent NZ-538101-A (NZ)
Title: Modular beverage container
Inventor: FITZPATRICK NEIL DEREK
Filed: 2005-02-08
Abstract: A beverage container having a first chamber and a second chamber, the chambers each holding different beverage components and being releasably attachable to one another such that there is a seal therebetween sufficient to prevent the beverage components from mixing, the first chamber having a conduit which can be forced against the seal when the chambers are attached to one another to break the seal and enable the components of the two chambers to mix to form a beverage, the conduit being formed to provide an exit for the beverage so that it can be consumed; the container being formed such that prior to the seal being broken the component of the first chamber is in contact with the conduit.
Patent NZ-538451-A (NZ)
Title: Single-step, highly sensitive yet specific and quantitative method to detect and quantify endothelial progenitor cells (EPCs) in human peripheral blood
Inventor: LIN EDWARD H
IPC: C12Q1/68
Filed: 2003-08-21
Abstract: Disclosed is a synthetic apolipoprotein-E mimicking polypeptide comprising an amino acid sequence selected from the group of (i) X-Y-Arg-Arg-Y-Y-X-X-Y-Y-Arg-Y-Y-Arg-X-Y-Y-X or the reverse sequence thereof, (ii) Arg-Arg-Y-Y-X-X-Y-Y-Arg-Y-Y-Arg-X-Y or the reverse sequence thereof, (iii) Y-Y-X-X-Y-Y-Arg-Y-Y-Arg-X-Y-Y-X or the reverse sequence thereof, and (iv) X-Y-Arg-Arg-Y-Y-X-X-Y-Y-Arg-Y-Y-Arg or the reverse sequence thereof, wherein X is glycine, threonine, serine or alanine, wherein Y is a hydrophobic amino acid, wherein the polypeptide comprises an acetyl group at the N-terminus and an amide group at the C-terminus, and wherein the polypeptide consists of a single domain.
Patent NZ-539871-A (NZ)
Title: Daily melatonin dosing units of 0.01 to 0.2 mg of melatonin or melatonin derivative, for promoting hair growth
Inventor: SCHMID HANS W
IPC: A61K9/00
Filed: 2003-10-30
Abstract: Disclosed is a single-use container for a topically applied medicament or cosmetic agent for promoting hair growth, comprising a single dose of 0.01 to 0.2 mg of melatonin or a melatonin derivative, which corresponds to a locally effective dose but does not have any systemic effect. The single does corresponds to a daily dose.
Patent NZ-541148-A (NZ)
Title: Aryl alkyl carbamate derivatives production and use thereof in therapy
Inventor: ABOUABDELLAH AHMED
IPC: C07D213/40
Filed: 2004-01-22
Abstract: Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification. The compounds can be prepared from compounds of formulae (Ia) and (V) by methods described herein. The compounds of formula (I) are FAAH enzyme inhibitors useful in the treatment of acute or chronic pain, dizziness, vomiting, nausea, eating disorders, neurological and psychiatric pathologies, acute or chronic neurodegenerative diseases, epilepsy, sleep disorders, cardiovascular diseases, renal ischaemia, cancers, disorders of the immune system, allergic diseases, parasitic, viral or bacterial infectious diseases, inflammatory diseases, osteoporosis, ocular conditions, pulmonary conditions, gastrointestinal diseases or urinary incontinence.
Patent NZ-550945-A (NZ)
Title: Anti-coronavirus compounds
Inventor: WONG CHI-HUEY
IPC: A01N47/10
Filed: 2005-05-03
Abstract: Disclosed is a compound of formula (I), or a salt thereof, wherein R5 and R11 are alkyl substituted with aryl, and wherein the rest of the substituents are as defined in the specification. Also disclosed is the use of the above compound for treating an infection with a coronavirus.
Patent NZ-552267-A (NZ)
Title: Pallet gripper with tines having actuators to internally grip pallet bearers
Inventor: LUCAS MICHAEL DAVID
Filed: 2003-12-10
Abstract: Side actuators 53 are provided which can contact bearers of a pallet (not shown) by extending from the tine external side surfaces. Optionally, vertically contacting actuators are provided to internally contact other parts of a pallet.
Patent NZ-562462-A (NZ)
Title: Nutritional supplement for HIV patients comprising acid and neutral oligosaccharides.
Inventor: GARSSEN JOHAN
IPC: A23L33/00
Filed: 2006-04-19
Abstract: A composition comprising an acid oligosaccharide, a neutral oligosaccharide and cysteine for the treatment or prevention of HIV or AIDS and symptoms associated with HIV infection. The invention is based on the finding that acid oligosaccharides can block DC-SIGN, a surface receptor involved in viral translocation from dendritic cells to CD4 T-cells. The acid oligosaccharide is prepared from pectin, pectate, alginate, chondroitine, hyaluronic acids, heparine, heparane, sialoglycans, fucoidan, fucooligosaccharides or carrageenan. The neutral oligosaccharide is selected from galactooligosaccharide, fructooligosaccharide, transgalactooligosccharide, xylooligo-saccharide, lactosurcrose, and arabinooligosacchardie. The cysteine can be from N-acetylcysteine, diacetylcysteine, whey, colostrum, and/or egg proteins.
Patent NZ-566533-A (NZ)
Title: Cyclopropyl amines as modulators of the histamine H3 receptor
Inventor: ALLISON BRETT D
IPC: A61K31/496
Filed: 2006-09-14
Abstract: Disclosed are the compounds (4-cyclopropylpiperazin-1-yl)-(4-morpholin-4-ylmethyl-phenyl)-methanone, (4-cyclopropylpiperazin-1-yl)-[4-(4-fluoro-piperidin-1-ylmethyl)-phenyl]-methanone, (4-5 cyclopropyl-piperazin-1-yl)-(4-thiomorpholin-4-ylmethyl-phenyl)-methanone, and (4-cyclopropyl-piperazin-1-yl)-[4-(2-hydroxymethyl-morpholin-4-ylmethyl)phenyl]-methanone, and enantiomers, hydrates, solvates, pharmaceutically acceptable salts and isotopically labelled forms thereof. The compounds are useful in the treatment of diseases including CNS disorders, upper airway allergic response, asthma, itch, nasal congestion and allergic rhinitis.
Patent NZ-567674-A (NZ)
Title: An insert with a grid and mesh and a morter cover preventing blockage removed after the wall is rendered
Inventor: FLINT JOHN NOEL
IPC: E04B1/72
Filed: 2007-01-05
Abstract: An insert for a weep hole opening in a masonry wall is disclosed. The insert includes a hollow body (2) defining an air flow conduit and including a first open end (4) and a second open end (5). A stainless steel mesh screen (6) extends across the conduit near the first open end (4) and prevents fire brands and sparks from passing through the body (2). A locating member, in the form of a grate (7), is connected to the body (2) adjacent the first open end (4) by a hinge. The screen (6) is located in a recess in the rear of the grate (7) and is retained by friction. The grate (7) is formed from a material that substantially retains its spatial integrity when exposed to the heat flux profile generated by a typical forest fire, such that the grate (7) continues thereafter to locate the screen (6). The grate (7) also has a plurality of ventilation apertures to allow air to pass through the air flow conduit. A mortar guard (10) releasably engages the grate (7) to cover the ventilation apertures (9) to prevent mortar clogging the apertures during rendering.
Patent NZ-570591-A (NZ)
Title: Anthelmintic compositions
Inventor: HILLIER CHARLES ROBERT
IPC: A61K31/429
Filed: 2009-08-18
Abstract: Disclosed is process for producing a stabilised anthelmintic composition comprising incorporating into a composition comprising a macrocyclic lactone (ML), levamisole or equivalent agent selected from morantel and pyrantel and a modified starch.
Patent NZ-574809-A (NZ)
Title: Biomimetic mechano-sensitive actuator array
Inventor: ANDERSON IAIN ALEXANDER
IPC: H01L41/09
Filed: 2010-02-01
Abstract: A biomimetic actuator array adapted for sequential actuation by way of mechanosensitivity propagating actuation through the array, a mechano-sensitive actuator adapted for use in a biomimetic actuator array, and a method of controlling an actuator in a biomimetic actuator array is disclosed. An array of actuators is provided which is adapted for sequential actuation by way of mechanosensitivity propagating actuation through the array, triggering each actuator upon deformation thereof caused by an adjacent actuator or a load in the form of a fluid or a solid object. Actuation is thus coordinated with minimal computational overhead. The mechano-sensitive actuator for use in a biomimetic actuator array comprises: (a) manipulation means for selectively manipulating a fluid or solid object; (b) sensing means for sensing deformation of the manipulation means; and (c) triggering means for actuating the manipulation means upon sensing deformation thereof where the actuator propagates actuation through the array by way of mechano-sensitivity.